Bullboard - Stock Discussion Forum Quest Pharmatech Inc V.QPT

Alternate Symbol(s): QPTFF

Healthcare Biotechnology

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy... see more

Add To Watchlist

TSXV:QPT - Post Discussion

Quest Pharmatech Inc > Hmm...

View:

Post by ARIMA11 on Jul 21, 2022 1:30pm

Hmm...

https://ceo.ca/qpt?628915064c02
https://pulsenews.co.kr/view.php?sc=30800028&year=2022&no=360177

Canariabio is issuing convertible bonds worth 70 billion won to finance the deal, along with 20 billion won pooled from its affiliated entities.

As pointed out by Zippo on CEO.ca, Canaribio continues to acquire companies. This time in the feed business. The way they make that acquisition is also through a convertable bonds. 90B this time.

In comparison the QPT deal is small potatoes but reading this is not comforting.

238

Comment

Comment by G1945V on Jul 21, 2022 1:38pm

Thanks ARIMA11, for the explanation. I did email Pierre Vermette. Have not heard back as yet. G1945V

121

Comment

Comment by G1945V on Jul 22, 2022 8:29am

I cannot believe that all of this new information as you are pointing out is not material news for the shareholders of Quest Pharmatech Inc. (QPT) Dr. Madi Madiyalakan being the CEO of both Quest Pharmatech (QPT) and OncoQuest Inc. should without further delay put out a news release outlining in detail all he expressed at the AGM telephone conference on July 19, 2022, as to what has ...more

187

Comment

Comment by ARIMA11 on Jul 22, 2022 5:31pm

https://ceo.ca/@newswire/quest-pharmatech-announces-results-from-agm-99616 On a corporate matter, Quest announces the granting of 1,300,000 stock options to Directors and Officers, all at a volume weighted average exercise price of $0.09 per common share, expiring 10 years from the date of grant, subject to TSX Venture Exchange approval. You'd think they would take the opportunity to ...more

201

Comment

Comment by PosNeg1 on Aug 17, 2022 4:39pm

10 Yrs is a joke, $ due from Korea by end of August. Lets see what happens

107

Comment

Comment by ARIMA11 on Sep 09, 2022 11:37am

(Google Translated) from Canaria Bio (Two items) 1. https://canariabio.com/ir/notice/?uid=86&mod=document&pageid=1 Notice to shareholders and stakeholders Posted bycanariabioPosted on 2022-09-05 11:23 Hello shareholders and stakeholders, As the media recently reported on the acquisitions of listed companies by Edison Motors and investment associations since June ...more

159

Comment

Comment by G1945V on Sep 13, 2022 8:48am

By now you would think that our CEO (Madi R. Madiyalakan) would step up to the plate to reassure us that all is well and that the deal OncoQuest made is still on track, seeing that he is the CEO of both Quest and OncoQuest. What's he really up to? What is really going on? G1945V

155

Comment

Quest Pharmatech Inc